Table 5.
Estimate | SE | 95% CI | p-value | |
---|---|---|---|---|
rs2118177 | −0.30 | 0.12 | [−0.5, −0.07] | 0.01 |
Age | −0.03 | 0.01 | [−0.05, −0.005] | 0.02 |
FEV1 % predicted | −0.03 | 0.01 | [−0.05, −0.01] | 0.01 |
Treatment Group | −0.55 | 0.19 | [−0.9, −0.18] | 0.004 |
Pack-years | 0.003 | 0.003 | [−0.004, 0.01] | 0.4 |
Gender | −0.14 | 0.19 | [−0.5, 0.2] | 0.5 |
rs2304566 | −0.37 | 0.12 | [−0.6, −0.1] | 0.002 |
Age | −0.03 | 0.01 | [−0.05, −0.004] | 0.02 |
FEV1 % predicted | −0.03 | 0.01 | [−0.05, −0.008] | 0.007 |
Treatment Group | −0.52 | 0.19 | [−0.9, −0.2] | 0.005 |
Pack-years | 0.003 | 0.003 | [−0.004, 0.01] | 0.4 |
Gender | −0.17 | 0.18 | [−0.5, 0.19] | 0.4 |
rs1130866 | −0.23 | 0.1 | [−0.42, −0.04] | 0.02 |
Age | −0.03 | 0.01 | [−0.05, −0.005] | 0.02 |
FEV1 % predicted | −0.03 | 0.01 | [−0.05, −0.007] | 0.01 |
Treatment Group | −0.50 | 0.2 | [−0.9, −0.1] | 0.008 |
Pack-years | 0.003 | 0.003 | [−0.004, 0.01] | 0.4 |
Gender | −0.12 | 0.19 | [−0.5, 0.3] | 0.5 |
rs3024791 | −0.61 | 0.18 | [−1.0, −0.3] | 0.0007 |
Age | −0.03 | 0.01 | [−0.05, −0.005] | 0.02 |
FEV1 % predicted | −0.03 | 0.01 | [−0.05, −0.008] | 0.009 |
Treatment Group | −0.53 | 0.19 | [−0.9, −0.2] | 0.006 |
Pack-years | 0.003 | 0.003 | [−0.004, 0.01] | 0.4 |
Gender | −0.10 | 0.19 | [−0.5, 0.2] | 0.5 |
rs2077079 | 0.01 | 0.12 | [−0.2, 0.2] | 0.9 |
Age | −0.03 | 0.01 | [−0.05, −0.004] | 0.02 |
FEV1 % predicted | −0.03 | 0.01 | [−0.05, −0.005] | 0.02 |
Treatment Group | −0.50 | 0.19 | [−0.9, −0.1] | 0.01 |
Pack-years | 0.002 | 0.003 | [−0.004, 0.01] | 0.5 |
Gender | −0.1 | 0.19 | [−0.5, 0.3] | 0.6 |
Treatment Group (1 = LVRS, 0 = medical)
Gender (1 = male, 0 = female)